4//SEC Filing
Kaplan Matthew L. 4
Accession 0001104659-24-071289
CIK 0001875558other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:22 PM ET
Size
4.9 KB
Accession
0001104659-24-071289
Insider Transaction Report
Form 4
Kaplan Matthew L.
Director
Transactions
- Award
Common Stock
2024-06-13+30,000→ 83,760 total
Footnotes (1)
- [F1]The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Kaplan's continued service on the board on such dates.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001895952
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:22 PM ET
- Size
- 4.9 KB